GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹7,888 Cr | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹7,888 Cr |
| Mar2025 | ₹7,157 Cr |
| Mar2024 | ₹6,788 Cr |
| Mar2023 | ₹6,015 Cr |
| Mar2022 | ₹5,234 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,888 Cr | 10.21 | |
| Mar2025 | ₹7,157 Cr | 5.44 | |
| Mar2024 | ₹6,788 Cr | 12.84 | |
| Mar2023 | ₹6,015 Cr | 14.92 | |
| Mar2022 | ₹5,234 Cr | - | |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹46,618.3 Cr | -7.2% | -3.1% | 48.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -7.2% |
-3.1% |
48.9% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses